Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
16-27 |
NCBITaxon:11118 |
denotes |
Coronavirus |
T2 |
127-136 |
UBERON:0002048 |
denotes |
Pulmonary |
T3 |
152-163 |
NCBITaxon:11118 |
denotes |
coronavirus |
T4 |
178-186 |
SP_7 |
denotes |
COVID-19 |
T5 |
230-235 |
NCBITaxon:10239 |
denotes |
viral |
T6 |
374-380 |
UBERON:0002113 |
denotes |
kidney |
T7 |
427-432 |
UBERON:0002113 |
denotes |
renal |
T8 |
654-662 |
SP_7 |
denotes |
COVID-19 |
T9 |
694-704 |
GO:0065007 |
denotes |
controlled |
T10 |
722-738 |
CHEBI:48561 |
denotes |
receptor blocker |
T11 |
722-738 |
CHEBI:48561 |
denotes |
receptor blocker |
T12 |
739-747 |
CHEBI:6541 |
denotes |
losartan |
T13 |
739-747 |
CHEBI:6541 |
denotes |
losartan |
T14 |
763-778 |
UBERON:0001621 |
denotes |
coronary artery |
T15 |
1091-1099 |
SP_7 |
denotes |
COVID-19 |
T16 |
1129-1140 |
UBERON:0001004 |
denotes |
respiratory |
T17 |
1246-1258 |
UBERON:0005169 |
denotes |
interstitial |
T18 |
1295-1298 |
UBERON:0000970 |
denotes |
eye |
T19 |
1326-1334 |
SP_7 |
denotes |
COVID-19 |
T20 |
1416-1427 |
UBERON:0001004 |
denotes |
respiratory |
T21 |
1490-1501 |
UBERON:0001004 |
denotes |
respiratory |
T22 |
1570-1578 |
SP_7 |
denotes |
COVID-19 |
T23 |
1673-1691 |
CHEBI:5801 |
denotes |
hydroxychloroquine |
T24 |
1673-1691 |
DG_20 |
denotes |
hydroxychloroquine |
T25 |
1673-1691 |
CHEBI:5801 |
denotes |
hydroxychloroquine |
T26 |
1696-1707 |
DG_35 |
denotes |
tocilizumab |